BG105847A - Calcilytic compounds - Google Patents

Calcilytic compounds

Info

Publication number
BG105847A
BG105847A BG105847A BG10584701A BG105847A BG 105847 A BG105847 A BG 105847A BG 105847 A BG105847 A BG 105847A BG 10584701 A BG10584701 A BG 10584701A BG 105847 A BG105847 A BG 105847A
Authority
BG
Bulgaria
Prior art keywords
calcilytic compounds
compounds
calcilytic
meanings
substituents
Prior art date
Application number
BG105847A
Other languages
Bulgarian (bg)
English (en)
Inventor
Amparo Lago
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG105847A publication Critical patent/BG105847A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Hydrogenated Pyridines (AREA)
BG105847A 1999-02-02 2001-08-27 Calcilytic compounds BG105847A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11824099P 1999-02-02 1999-02-02
PCT/US2000/002676 WO2000045816A1 (en) 1999-02-02 2000-02-02 Calcilytic compounds

Publications (1)

Publication Number Publication Date
BG105847A true BG105847A (en) 2002-04-30

Family

ID=22377367

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105847A BG105847A (en) 1999-02-02 2001-08-27 Calcilytic compounds

Country Status (24)

Country Link
US (1) US6417215B1 (ko)
EP (1) EP1148876A4 (ko)
JP (1) JP2002536330A (ko)
KR (1) KR20010093285A (ko)
CN (1) CN1346269A (ko)
AP (1) AP2001002220A0 (ko)
AU (1) AU3480200A (ko)
BG (1) BG105847A (ko)
BR (1) BR0007922A (ko)
CA (1) CA2361589A1 (ko)
CO (1) CO5251439A1 (ko)
CZ (1) CZ20012797A3 (ko)
EA (1) EA200100854A1 (ko)
HK (1) HK1042036A1 (ko)
HU (1) HUP0200121A3 (ko)
ID (1) ID29533A (ko)
IL (1) IL144470A0 (ko)
MA (1) MA25379A1 (ko)
NO (1) NO20013769L (ko)
OA (1) OA11757A (ko)
PE (1) PE20001456A1 (ko)
SK (1) SK10982001A3 (ko)
WO (1) WO2000045816A1 (ko)
ZA (1) ZA200106298B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002014259A1 (fr) * 2000-08-11 2002-02-21 Japan Tobacco Inc. Antagonistes du recepteur de calcium
WO2002034204A2 (en) * 2000-10-25 2002-05-02 Smithkline Beecham Corporation Calcilytic compounds
US6864267B2 (en) * 2001-07-16 2005-03-08 Smithkline Beecham Corporation Calcilytic compounds
UY28089A1 (es) * 2002-11-26 2004-06-30 Smithkline Beecham Corp Compuestos calciliticos
US7105537B2 (en) 2003-01-28 2006-09-12 Bristol-Myers Squibb Company 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
AR044075A1 (es) * 2003-04-23 2005-08-24 Japan Tobacco Inc Antagonista de un receptor sensible al calcio
EP1630157A4 (en) 2003-05-28 2007-05-23 Japan Tobacco Inc ANTAGONIST OF CASR
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
EP1964548A1 (en) * 2007-03-02 2008-09-03 Novartis AG Pharmaceutical compositions comprising a calcilytic agent
JP5025795B2 (ja) 2008-06-05 2012-09-12 旭化成ファーマ株式会社 スルホンアミド化合物及びその用途
WO2010103429A1 (en) 2009-03-10 2010-09-16 Pfizer Inc. 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
WO2021029517A1 (en) * 2019-08-13 2021-02-18 Dongguk University Industry-Academic Cooperation Foundation Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97219A (en) * 1990-02-19 1995-12-08 Ciba Geigy Ag Elliptical amino compounds converted by biphenyl process for their preparation and pharmaceutical preparations containing them
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO1997037967A1 (en) * 1996-04-09 1997-10-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
PE20001456A1 (es) 2001-01-28
CO5251439A1 (es) 2003-02-28
BR0007922A (pt) 2001-11-06
WO2000045816A1 (en) 2000-08-10
JP2002536330A (ja) 2002-10-29
HUP0200121A2 (hu) 2002-05-29
ID29533A (id) 2001-09-06
NO20013769L (no) 2001-09-26
OA11757A (en) 2005-07-19
US6417215B1 (en) 2002-07-09
EP1148876A4 (en) 2003-07-23
KR20010093285A (ko) 2001-10-27
EP1148876A1 (en) 2001-10-31
CZ20012797A3 (cs) 2002-01-16
CN1346269A (zh) 2002-04-24
ZA200106298B (en) 2002-10-18
MA25379A1 (fr) 2002-04-01
SK10982001A3 (sk) 2001-12-03
IL144470A0 (en) 2002-05-23
NO20013769D0 (no) 2001-08-01
AU3480200A (en) 2000-08-25
CA2361589A1 (en) 2000-08-10
EA200100854A1 (ru) 2002-02-28
AP2001002220A0 (en) 2001-09-30
HUP0200121A3 (en) 2002-11-28
HK1042036A1 (zh) 2002-08-02

Similar Documents

Publication Publication Date Title
HK1066810A1 (en) Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
MY129613A (en) Cannabinoid receptor binding compounds
MXPA02011977A (es) Herbicidas de piridina sustituidas.
BG106585A (en) Kinase inhibitors as therapeutic agents
MY134568A (en) Cb2 receptor agonists
DE60012188D1 (de) Fungizide
ATE245636T1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
BG102704A (en) Fungicide 2-methoxybenzophenons
BG106440A (en) Nitrogen-heterocyclic derivatives as nos inhibitors
BG105515A (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
BG105205A (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
RS20050810A (en) 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BG103485A (en) Ketobanzamides as calpain inhibitors
HK1068136A1 (en) Muscarinic antagonists
BG105847A (en) Calcilytic compounds
BG104916A (en) Calcilytic compounds
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
BG104915A (en) Azabicyclic 5hti receptor ligands
BG105710A (en) 5ht1 antagonists for antidepressant therapy
GB0018951D0 (en) Novel compounds
MXPA03011630A (es) Compuestos de amenoacetonitrilo para el control de endoparasitos.
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
SE9903290D0 (sv) Novel compounds
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила